• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《“30MO ORIENT-3:一项关于信迪利单抗与多西他赛在既往治疗的晚期/转移性鳞状非小细胞肺癌(sqNSCLC)中的随机、开放标签、III期研究”撤稿声明》:[《肿瘤学年鉴》第31卷,增刊7,2020年12月,第S1428页]

Retraction notice to "30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)": [Annals of Oncology Volume 31, Supplement 7, December 2020, Page S1428].

作者信息

Shi Y, Wu L, Yu X, Xing P, Zhou J, Wang A, Shi J, Hu Y, Wang Z, An G, Fang Y, Sun S, Zhou C, Wang C, Ye F, Li X, Wang J, Wang M, Liu Y, Zhao Y

机构信息

Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Department II of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China.

出版信息

Ann Oncol. 2021 Apr;32(4):576. doi: 10.1016/j.annonc.2021.01.009.

DOI:10.1016/j.annonc.2021.01.009
PMID:33736838
Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article was retracted at the request of the authors. The authors of this abstract have advised that full agreement between authors and sponsors on publication of the abstract has not been reached and they are therefore unable to publish this data at present.

摘要

本文已被撤回

请参阅爱思唯尔关于文章撤回的政策(https://www.elsevier.com/about/our-business/policies/article-withdrawal)。本文应作者要求被撤回。该摘要的作者表示,作者与赞助商之间尚未就该摘要的发表达成完全一致,因此他们目前无法发表此数据。

相似文献

1
Retraction notice to "30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)": [Annals of Oncology Volume 31, Supplement 7, December 2020, Page S1428].《“30MO ORIENT-3:一项关于信迪利单抗与多西他赛在既往治疗的晚期/转移性鳞状非小细胞肺癌(sqNSCLC)中的随机、开放标签、III期研究”撤稿声明》:[《肿瘤学年鉴》第31卷,增刊7,2020年12月,第S1428页]
Ann Oncol. 2021 Apr;32(4):576. doi: 10.1016/j.annonc.2021.01.009.
2
RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC).撤回:ORIENT-3:一项关于信迪利单抗与多西他赛对比用于既往治疗过的晚期/转移性鳞状非小细胞肺癌(sqNSCLC)的随机、开放标签III期研究。
Ann Oncol. 2020 Dec;31 Suppl 7:S1428. doi: 10.1016/j.annonc.2020.10.517. Epub 2020 Dec 13.
3
Retraction notice to "Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database" [Comput. Biol. Med. 139 (2021) 104981].撤回声明:“对从全球共享流感数据倡议组织(GISAID)数据库中检索到的329,942条严重急性呼吸综合征冠状病毒2(SARS-CoV-2)记录的分析” [《计算机生物学与医学》139 (2021) 104981] 。
Comput Biol Med. 2022 Jul;146:105527. doi: 10.1016/j.compbiomed.2022.105527. Epub 2022 Apr 20.
4
Retraction notice to: "Characteristics of recursive backstepping algorithm and active damping of oscillations in feedback linearization for electromechanical system with extended stability analysis and perturbation rejection" [ISA Trans. 64C (2016) 365-372].撤回通知:“具有扩展稳定性分析和扰动抑制的机电系统反馈线性化中递归反步算法的特性及振荡的主动阻尼”[《ISA 学报》64C 卷(2016 年)365 - 372 页]。
ISA Trans. 2018 Dec;83:304. doi: 10.1016/j.isatra.2018.11.008. Epub 2018 Nov 19.
5
Retraction notice to "A SERS-based lateral flow assay biosensor for quantitative and ultrasensitive detection of interleukin-6 in unprocessed whole blood" [Biosens. Bioelectron. 141 (2019) 111432].撤回通知:“一种基于表面增强拉曼光谱的侧向流动分析生物传感器用于未处理全血中白细胞介素-6的定量和超灵敏检测”[生物传感器与生物电子学141 (2019) 111432]
Biosens Bioelectron. 2020 Nov 15;168:112415. doi: 10.1016/j.bios.2020.112415. Epub 2020 Sep 13.
6
Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399].对“增强型AC133特异性嵌合抗原受体T细胞疗法诱导转移性小细胞肺癌小鼠长期缓解”[《癌症快报》520 (2021) 385 - 399]的撤稿通知
Cancer Lett. 2022 Jul 1;537:215680. doi: 10.1016/j.canlet.2022.215680. Epub 2022 Apr 20.
7
Retraction notice to "Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines" [Surgical Neurology 68 (2007) 613-614].撤回通知:“恶性胶质瘤细胞系中辐射增强肝细胞生长因子分泌”[《外科神经学》68(2007)613 - 614]
World Neurosurg. 2018 Nov;119:530. doi: 10.1016/j.wneu.2018.09.021.
8
Retraction notice to "Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia" [Life Sci. 100 (2014) 97-109].对“褪黑素通过蛋白激酶C介导的水通道蛋白-4抑制在局灶性脑缺血动物模型中发挥神经保护作用”[《生命科学》100 (2014) 97 - 109]的撤稿通知
Life Sci. 2021 Sep 15;281:119209. doi: 10.1016/j.lfs.2021.119209. Epub 2021 Jul 7.
9
Retraction notice to "Attractiveness of women with rectovaginal endometriosis: a case-control study" [FNS 99 (2013) 212 - 218].撤回通知:“直肠阴道子宫内膜异位症女性的吸引力:一项病例对照研究”[《妇产科护理与研究》99(2013年)212 - 218页]
Fertil Steril. 2020 Nov;114(5):1123. doi: 10.1016/j.fertnstert.2020.09.001.
10
Retraction notice to influence of nucleotomy on the load sharing in the spinal facet joint under the loading scenarios of different human postures.关于“不同人体姿势加载情况下髓核摘除术对脊柱小关节负荷分担的影响”的撤稿通知
Med Eng Phys. 2022 Apr;102:103763. doi: 10.1016/j.medengphy.2022.103763. Epub 2022 Feb 23.

引用本文的文献

1
[Anti-angiogenesis in Lung Cancer: Current Situation, Progress and Confusion].[肺癌中的抗血管生成:现状、进展与困惑]
Zhongguo Fei Ai Za Zhi. 2022 Apr 20;25(4):278-286. doi: 10.3779/j.issn.1009-3419.2022.101.16.
2
Therapeutic advances in non-small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy.非小细胞肺癌的治疗进展:聚焦于靶向治疗和免疫治疗的临床开发
MedComm (2020). 2021 Dec 14;2(4):692-729. doi: 10.1002/mco2.105. eCollection 2021 Dec.